{"nct_id":"NCT03162614","title":"Efficacy, Immunogenicity and Safety Study of GSK Biologicals' Candidate Malaria Vaccine Evaluating Different Dose Schedules in a Sporozoite Challenge Model in Healthy Malaria-naïve Adults","status":"COMPLETED","status_verified_date":"2020-10","start_date":"2017-05-24","start_date_type":"ACTUAL","primary_completion_date":"2018-07-09","primary_completion_date_type":"ACTUAL","completion_date":"2018-09-24","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GSK"]}